open access

Vol 12, No 2 (2017)
Case Reports
Published online: 2017-04-20
Get Citation

FFR not always conclusive… A patient with a hemodynamically insignificant lesion in coronary artery and myocardial infarction

Paweł Czerwonka, Iwona Gorczyca-Michta, Alicja Stępień-Wałek, Beata Wożakowska-Kapłon
DOI: 10.5603/FC.2017.0033
·
Folia Cardiologica 2017;12(2):211-214.

open access

Vol 12, No 2 (2017)
Case Reports
Published online: 2017-04-20

Abstract

Assessment of partial flow reserve (FFR) is important in identifying hemodynamically significant coronary artery stenosis. Its result is an important criterion for further treatment. However, it should be noted that therapeutic decisions should not be made based only on the positive result of the FFR, especially in the blood vessels with subcritical lesions.

Abstract

Assessment of partial flow reserve (FFR) is important in identifying hemodynamically significant coronary artery stenosis. Its result is an important criterion for further treatment. However, it should be noted that therapeutic decisions should not be made based only on the positive result of the FFR, especially in the blood vessels with subcritical lesions.

Full Text:

View HTML
Get Citation

Keywords

FFR, fractional flow reserve, subcritical lesions, NSTEMI

About this article
Title

FFR not always conclusive… A patient with a hemodynamically insignificant lesion in coronary artery and myocardial infarction

Journal

Folia Cardiologica

Issue

Vol 12, No 2 (2017)

Pages

211-214

Published online

2017-04-20

DOI

10.5603/FC.2017.0033

Bibliographic record

Folia Cardiologica 2017;12(2):211-214.

Keywords

FFR
fractional flow reserve
subcritical lesions
NSTEMI

Authors

Paweł Czerwonka
Iwona Gorczyca-Michta
Alicja Stępień-Wałek
Beata Wożakowska-Kapłon

References (8)
  1. Lanza GA, Careri G, Crea F. Mechanisms of coronary artery spasm. Circulation. 2011; 124(16): 1774–1782.
  2. Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010; 121(21): 2317–2325.
  3. Ziadi MC, Dekemp RA, Williams KA, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011; 58(7): 740–748.
  4. De Bruyne B, Pijls NHJ, Kalesan B, et al. FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012; 367(11): 991–1001.
  5. Tonino PA, De Bruyne B, Pijls NH, et al. FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009; 360(3): 213–224.
  6. Sels JWEM, Tonino PAL, Siebert U, et al. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. JACC Cardiovasc Interv. 2011; 4(11): 1183–1189.
  7. Roffi M, Patrono C, Collet JP, et al. Authors. [2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]. [Article in Polish]. Kardiol Pol. 2015;73(12):1207-94. 2015; 73(12): 1207–1294.
  8. Tonino PAL, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010; 55(25): 2816–2821.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl